Can-Fite Biopharma Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Arius Research Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Ariad Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Aphton Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Active Biotech Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Adventrx Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Aeterna Zentaris Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Alfacell Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Allos Therapeutics Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Amgen Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Angiogene Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Anormed Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Anosys Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Anticancer Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Antigenics Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Antisense Pharma Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005